World

SK bioscience’s World First Cell Culture-Based Influenza Vaccine Is Approved in Chile

The world first cell culture-based influenza vaccine, ‘SKYCellflu™’ is approved for the first time in South America  SKYCellflu&t...

 February 02, 2023 | News

Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market

Clinical development pipeline is essential to global business strategy Vetter Development Service offers comprehensive expertise for in-human trial mate...

 February 02, 2023 | News

Eppendorf & Science Prize for Neurobiology 2023 Call for Entries!

This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based ...

 February 02, 2023 | News

TransCode Therapeutics Reports Positive Preclinical Results with its Immunotherapy Candidate, TTX-RIGA, in Melanoma

TransCode Therapeutics, Inc. (Nasdaq: RNAZ), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today repor...

 February 01, 2023 | News

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

Consolidated Manufacturing, Sales, Marketing, Operations to Provide Synergistic Cost Savings Biosynex SA (“Biosynex”) (EPA: ALBIO), a French m...

 February 01, 2023 | News

Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short

The 2022 G-FINDER Report, released today, reveals that for the year 2021, global funding for the development of critical new health technologies to overcom...

 February 01, 2023 | News

Charles River Laboratories Acquires SAMDI Tech

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has acquired SAMDI Tech, Inc, a leading provider of high-quality, l...

 January 31, 2023 | News

Pfizer Expands ‘An Accord for a Healthier World’ Product Offering

Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights. Expands o...

 January 31, 2023 | News

Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28

Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2023 after the stock market closes on Tuesday, Feb....

 January 31, 2023 | News

Moderna Granted FDA Breakthrough Therapy Designation for Mrna-1345, an Investigational Respiratory Syncytial Virus (Rsv) Vaccine Candidate

 Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced mRNA-1345, an investig...

 January 30, 2023 | News

Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Based Companion Diagnostic Test for Tagrisso

As part of a global, multiyear agreement, Thermo Fisher Scientific today announced it is working with AstraZeneca to develop a solid tissue and blood-...

 January 24, 2023 | News

New Eppendorf Conical Tubes 25 mL variants for even better sample recovery

The innovative material of the amber-colored Conical Tubes 25 mL is highly transparent, while at the same time effectively protecting the sample from low-w...

 January 24, 2023 | News

Ingenovis Health Announces New Webinar Series for Clinicians

Top healthcare talent and workforce provider, Ingenovis Health (Ingenovis), is launching a new webinar series for clinicians. The ACT Webinar Series for He...

 January 23, 2023 | News

AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.

On 9 January 2023, AstraZeneca announced that it had entered into a definitive agreement to acquire CinCor. Following the successful closing of the tender ...

 January 23, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close